IM+ Capitals Limited (511628) fair value: what the stock is really worth
As of Oct 1, 2026: fair value of IM+ Capitals Limited ₹124, price ₹63.68, upside +95.1%, quality 36 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch IM+ Capitals Limited for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 27, 2026.
How to read this chart
60‑month range ₹4.06 – ₹119.85 · fair‑value band ₹111.03 – ₹156.35 · the ₹63.68 price screens below the ₹124.22 fair value. Dashed = 300-day average. As of Sep 27, 2026.
Follow IM+ Capitals in your weekly email
Every Wednesday you see whether IM+ Capitals is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
IM+ Capitals Limited engages in the finance and investment activities in India. It also offers asset management and distress debt resolution advisory services. The company was formerly known as Brescon Advisors & Holdings Limited and changed its name to IM+ Capitals Limited in June 2013.
Show more
IM+ Capitals Limited engages in the finance and investment activities in India. It also offers asset management and distress debt resolution advisory services. The company was formerly known as Brescon Advisors & Holdings Limited and changed its name to IM+ Capitals Limited in June 2013. IM+ Capitals Limited was founded in 1991 and is based in New Delhi, India.
Stock analysis
IM+ Capitals Limited (511628) currently trades at ₹63.68, while our model-based Fair Value estimate is ₹124.22, implying the stock looks roughly 48.7% undervalued today.
Show more
Valuation
How firm this estimate is: it rests on 18 models at a data quality of 96/100, which puts the evidence level at low.
Scenario range: ₹111.03 (bear) to ₹156.35 (bull), the price of ₹63.68 sits below it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 36/100 (below-average quality), in the Financials sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
IM+ Capitals Limited reported revenue of ₹3.4B in FY2026 versus ₹24.6M in FY2022, a compound +244.0%/yr. Reported net income was ₹913M in FY2026, compounding +211.8%/yr from FY2022. FY2022 was a trough year, so the rate overstates the trend.
Key figures
Market cap ₹104M (≈ $1.1M) · P/E ratio 9.6 · P/S ratio 2.54 · EPS (TTM) ₹3.09 · Net margin 26.5% · Return on assets (EBIT) 2.4% · Free cash flow ₹74.4M · Net debt ₹660M.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 50 out of 100 (low confidence).
What moves the price
The share trades about 5% below its 52-week high and 102% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Financials peers we cover trades at 9% fair-value upside, at 95%, 511628 screens cheaper than that median.
Fair Value models
Bear ₹111.03Fair Value ₹124.22Bull ₹156.35
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2026 figures (about 6 months old). Earnings retained since then (₹1.57 per share) are deliberately not added.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.62/100
The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Revenue growth 1 year
−18.9%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+44.0%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+141.2%
Start year 2021 (pandemic). Over 10 years: +44.1% a year
Revenue growth 12 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+44.3%
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
’26
What shareholders gained per year (last 5 years), in INR ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in INR: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+8.0%
Earnings growth per share plus dividend.
Earnings per share, growth per year+8.0%
Dividend (yield on the price)0.0%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.8.0% vs 6.3%, steady
Profit margin 2021 to 2026 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.54% → −4%
Start year 2021 (pandemic)
⚠ Revenue per share shrinking 1.3%/yr over ~7Y (margins eroding too) ⓘStructural-decline marker: revenue PER SHARE has fallen over the last decade (robust median trend, not a single year). Backtested across 2005 to 2017, such businesses trailed the market by about 2.5 percentage points per year. Display only: it does not change the fair value or the quality score.
Growth Forecast
Little optimism in the price
The price assumes less growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+62.9%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (India: IMF forecast 4.1% a year to 2030, 4.7% from 2016 to 2025) that is about +56.4% a year for the price.
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its sector: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median. (Industry “Investment Banking & Brokerage” was too small, so the broader sector is used.)Financials · 3198 stocks
Beats the sector median on 3/7 measures
A mixed picture versus its sector peers.
Valuation
Quality Score38 · Bottom 25%
Fair Value upside+95.1% · Top 25%
Profitability
Return on assets0.0% · Bottom 25%
Net margin (TTM)26.5% · Above median
Operating margin (TTM)0.0% · Bottom 25%
Growth and dividend
Revenue growth0.0% · Below median
Valuation Multiplesvs Financials median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is IM+ Capitals Limited (511628) overvalued or undervalued?
As of Sep 27, 2026, our model estimates a fair value of ₹124.22 versus a price of ₹63.68, about +95% upside (undervalued).
What is the fair value of 511628?
Our model-based fair value for IM+ Capitals Limited is ₹124.22 (as of Sep 27, 2026), built from audited fundamentals. The current price: ₹63.68.
What is the quality score of 511628?
IM+ Capitals Limited has a Quality Score of 36/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for IM+ Capitals Limited (511628)?
Our model-based price target is the fair value of ₹124.22 (as of Sep 27, 2026) from 4 valuation models. Cautious scenario ₹111.03, optimistic scenario ₹156.35. It is a calculation from audited fundamentals, not an analyst target.
What is the IM+ Capitals Limited stock forecast for 2026?
Our models put fair value at ₹124.22, about +95% upside versus a price of ₹63.68 (undervalued). Cautious scenario ₹111.03, optimistic scenario ₹156.35. The calculation is refreshed regularly with new filings.
What growth is priced into IM+ Capitals Limited (511628)?
For today's price to be fair in a discounted-cash-flow model, IM+ Capitals Limited would have to grow free cash flow by +62.9 % per year for five years (discount rate 12.4 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +141.2 % per year. As of Sep 27, 2026.
What discount rate (WACC) does the fair value of 511628 use?
Our models discount IM+ Capitals Limited at 12.4 %: a base by market capitalisation (nano), country premium for India. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For IM+ Capitals Limited that is +62.9 % per year a year over ten years, using the same discount rate (12.4 %) and the same formula as our fair value.
How much growth has IM+ Capitals Limited (511628) delivered so far?
Over the past 5 years revenue at IM+ Capitals Limited grew +141.2 % a year. The price currently implies +62.9 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of IM+ Capitals Limited (511628) growing?
The median revenue growth in the sector is +8.1 % a year. That is the yardstick for the growth priced into IM+ Capitals Limited (+62.9 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of IM+ Capitals Limited (511628)?
The free-cash-flow yield on the price is 0.58 %: that much free cash flow IM+ Capitals Limited produces per unit of market value. When it exceeds the discount rate of our models (12.4 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of IM+ Capitals Limited (511628)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For IM+ Capitals Limited it is ₹124.22 per share (as of Sep 27, 2026), against a price of ₹63.68. It is the blended result of 4 valuation models (cash flow, earnings, asset, dividend).
Is IM+ Capitals Limited stock overvalued or undervalued in 2026?
As of Sep 27, 2026, 511628 trades below its calculated fair value: price ₹63.68, fair value ₹124.22, a gap of about +95% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 511628?
No. The price is what the market pays today (₹63.68); the fair value is what the company's own numbers justify (₹124.22). For IM+ Capitals Limited the two are ₹60.54 per share apart. That gap is exactly why we show both numbers side by side.
How much is IM+ Capitals Limited worth?
The market values IM+ Capitals Limited at about ₹104M (market capitalisation, as of Sep 27, 2026). Per share that is ₹63.68; our models calculate a fair value of ₹124.22 per share.
What do the bullish and bearish scenarios say about 511628?
Our models span a range for IM+ Capitals Limited: cautious scenario ₹111.03, base ₹124.22, optimistic ₹156.35 per share (as of Sep 27, 2026, price ₹63.68). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 511628?
IM+ Capitals Limited trades at a price-to-earnings ratio of 9.6 (as of Sep 27, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of ₹124.22 is built from several models across several years.
How far is 511628 from its 52-week high?
IM+ Capitals Limited trades at ₹63.68, about 5% below its 52-week high of ₹67.33 and 102% above the low of ₹31.51 (as of Oct 1, 2026). Distance from the high says nothing about value: that is what the fair value of ₹124.22 is for.
Which stocks are comparable to IM+ Capitals Limited?
From the same area (Financials) we also value MADHUSE, AJCON, MKTCREAT, MODRNSH, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is IM+ Capitals Limited stock attractive at the current price?
The data as of Sep 27, 2026: price ₹63.68, calculated fair value ₹124.22 (+95%), Quality Score 36/100, from 4 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 511628 calculated?
We run IM+ Capitals Limited through 4 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of ₹124.22, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.5 % above its aggregate fair value. IM+ Capitals Limited currently trades 49 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of IM+ Capitals Limited (511628)?
The closing price on Oct 1, 2026 was ₹63.68. Our model-based fair value is ₹124.22, about +95% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with IM+ Capitals Limited right now?
The large discount to fair value meets weak quality (36/100). That raises the risk this is a value trap rather than a bargain. The price is below even our cautious bear case (₹111.03). The market is more pessimistic than our downside scenario. The large gap to fair value rests on thin data (low evidence): fewer applicable models and a shorter history. Read it with extra caution. For a financial, book-value and earnings-based methods matter more than a cash-flow DCF, which fits banks and insurers poorly.
Key figures of IM+ Capitals Limited
How large is the market capitalisation of IM+ Capitals Limited (511628)?
The market capitalisation of IM+ Capitals Limited is ₹104M (≈ $1.1M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of IM+ Capitals Limited (511628)?
The price-to-sales ratio of IM+ Capitals Limited is 2.54 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of IM+ Capitals Limited (511628)?
Earnings per share at IM+ Capitals Limited are ₹3.09 (price ÷ EPS = P/E 9.6). Earnings per share over the last twelve months: total profit spread across every single share.
What is the net margin of IM+ Capitals Limited (511628)?
The net margin of IM+ Capitals Limited is 26.5% (fiscal year 2026). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the EBIT return on assets of IM+ Capitals Limited (511628)?
On an EBIT basis the return on assets of IM+ Capitals Limited is 2.4% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
How much net debt does IM+ Capitals Limited (511628) carry?
The net debt of IM+ Capitals Limited is ₹660M (fiscal year 2026, ≈ 8.9 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch IM+ Capitals Limited in the live analysis
One click puts IM+ Capitals Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
